Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related Behavior
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
A common single-nucleotide polymorphism in the brain-derived neurotrophic factor (BDNF) gene, a methionine (Met) substitution for valine (Val) at codon 66 (Val66Met), is associated with alterations in brain anatomy and memory, but its relevance to clinical disorders is unclear. We generated a variant BDNF mouse (BDNF Met/Met ) that reproduces the phenotypic hallmarks in humans with the variant allele. BDNF Met was expressed in brain at normal levels, but its secretion from neurons was defective. When placed in stressful settings, BDNF Met/Met mice exhibited increased anxiety-related behaviors that were not normalized by the antidepressant, fluoxetine. A variant BDNF may thus play a key role in genetic predispositions to anxiety and depressive disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In rodents, BDNF haploinsufficiency resulted in smaller hippocampal volume and increased anxiety-related behaviors when exposed to chronic stress80, 81.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [80]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The BDNF Met polymorphism blocks the processing and activity-dependent release of mature BDNF (33).”
From Sestrin modulator NV-5138 produces rapid antidepressant effects via direct mTORC1 activation (2019) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In support of this, mice expressing the human BDNFVal66met (rs6265) single nucleotide polymorphism (SNP) – especially Met/Met carriers –, which induces deficits in BDNF processing and activity-dependent secretion 162, do not manifest ketamine-induced antidepressant effects 163.”
From Mechanisms of ketamine action as an antidepressant (2018) · cites this paper as [162]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mice homozygous for this BDNF SNP (BDNF met/met) recapitulate the memory phenotypes reported in humans with this SNP (Chen et al., 2006).”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Chen et al., 2006
The cited source says what the claim attributes to it.
In the citing paper
“The BDNF met/met mice were also unresponsive to chronic treatment with the antidepressant fluoxetine presumably through deficits in BDNF secretion (Chen et al., 2006).”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Chen et al., 2006
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., & Weinberger, D. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06690.2003 · Cited by 1,045
Pezawas, L., Verchinski, B. A., Mattay, V. S., Callicott, J. H., Kolachana, B. S., Straub, R. E., Egan, M. F., Meyer-Lindenberg, A., & Weinberger, D. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2680-04.2004 · Cited by 890
Chen, Z.-Y., Patel, P. D., Sant, G., Meng, C.-X., Teng, K. K., Hempstead, B. L., & Lee, F. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0348-04.2004 · Cited by 874
Self-citationPlasticity of the Hippocampus: Adaptation to Chronic Stress and Allostatic Load
McEwen, B. S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05830.x · Cited by 873
Self-citationLyons, W. E., Mamounas, L. A., Ricaurte, G. A., Coppola, V., Reid, S. W., Bora, S. H., Wihler, C., Koliatsos, V. E., & Tessarollo, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15239 · Cited by 865
Research works printed but not linked: 3
- 10.1016/j.biopsych.2005.09.022 · DOI · Paper page
- 10.1210/mend.15.10.0706 · DOI · Paper page
- Supported by the National Alliance for Research on Schizophrenia and Depression (F.S.L. Z.-Y.C. D.G.H.); DeWitt-Wallace Fund of the New York Community Trust (F.S.L. D.G.H.); Nancy Pritzker Depression Network (F.S.L. D.G.H.); Sackler Institute (F.S.L.); Foundation for the author of National Excellent Doctoral Dissertation of People's Republic of China (No. 200229) (Z.-Y.C.); Shanghai Rising-Star Program (05QMH1401) (Z.-Y.C.); Taishan Scholar Program (Z.-Y.C.); National Key Basic Research Program 2006CB503800 (Z.-Y.C.); and NIH (NS052819 to F.S.L. MH068850 to F.S.L. NS30687 to B.L.H. and MH060478 to K.G.B.). We thank M. Chao L. Tessarollo F. Maxfield C. Dreyfus C. Glatt P. Perez and K. Teng for helpful discussions.
Cited by
Items 101–200 of 210
Measurements of brain-derived neurotrophic factor. Methodological aspects and demographical data.
Trajkovska, V., Marcussen, A. B., Vinberg, M., Hartvig, P., Aznar, S., & Knudsen, G. M. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.03.009 · Cited by 203
Activity-dependent neural plasticity from bench to bedside
Ganguly, K., & Poo, M.-M. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.028 · Cited by 202
MICHELSEN, K., PRICKAERTS, J., & STEINBUSCH, H. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00912-6 · Cited by 196
“This is agreement with an animal study, where transgenic mice carrying two alleles of the Val66Met SNP displayed increased anxiety-related behaviour, and did not respond to SSRI treatment (Chen et al., 2006).”
ResultCell atrophy and loss in depression: reversal by antidepressant treatment
Banasr, M., Dwyer, J. M., & Duman, R. S. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.09.002 · Cited by 201
Role of BDNF epigenetics in activity-dependent neuronal plasticity
Karpova, N. N. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.002 · Cited by 200
“These findings implicate improper BDNF sorting in the learning and memory impairments and susceptibility to mood disorders of Met allele carriers (Chen et al., 2006; Krishnan et al., 2007; Soliman et al., 2010).”
BackgroundKunugi, H., Hori, H., Adachi, N., & Numakawa, T. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02135.x · Cited by 200
Stress effects on BDNF expression: Effects of age, sex, and form of stress
Bath, K. G., Schilit, A., & Lee, F. S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.074 · Cited by 197
Self-citationKoshimizu, H., Kiyosue, K., Hara, T., Hazama, S., Suzuki, S., Uegaki, K., Nagappan, G., Zaitsev, E., Hirokawa, T., Tatsu, Y., et al. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-27 · Cited by 195
Cellular and molecular mechanisms in the long-term action of antidepressants.
Racagni, G., & Popoli, M. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/gracagni · Cited by 192
Fukumoto, K., Fogaça, M. V., Liu, R.-J., Duman, C., Kato, T., Li, X.-Y., & Duman, R. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814709116 · Cited by 188
“Notably, the synaptic and antidepressant behavioral responses to ketamine are blocked both in BDNF Val66Met knockin mice (12), in which the processing and activity-dependent release of BDNF is blocked (19), and by infusion of a BDNF nAb into the mPFC (14).”
BackgroundNeurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine
Deyama, S., & Duman, R. S. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172837 · Cited by 186
Stratified medicine for mental disorders
Schumann, G., Binder, E. B., Holte, A., de Kloet, E. R., Oedegaard, K. J., Robbins, T. W., Walker-Tilley, T. R., Bitter, I., Brown, V. J., Buitelaar, J., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.010 · Cited by 186
Hippocampal–Prefrontal BDNF and Memory for Fear Extinction
Rosas-Vidal, L. E., Do-Monte, F. H., Sotres-Bayon, F., & Quirk, G. J. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.64 · Cited by 184
Association of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide
Youssef, M. M., Underwood, M. D., Huang, Y.-Y., Hsiung, S.-C., Liu, Y., Simpson, N. R., Bakalian, M. J., Rosoklija, G. B., Dwork, A. J., Arango, V., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy008 · Cited by 183
“, 2004), and anxiety-related behaviors in animal models (Chen et al., 2006), although not all studies agree (Sen et al.”
InfluentialReduced Structural Connectivity of a Major Frontolimbic Pathway in Generalized Anxiety Disorder
Tromp, D. P. M., Grupe, D. W., Oathes, D. J., McFarlin, D. R., Hernandez, P. J., Kral, T. R. A., Lee, J. E., Adams, M., Alexander, A. L., & Nitschke, J. B. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2178 · Cited by 184
Ninan, I., Bath, K. G., Dagar, K., Perez-Castro, R., Plummer, M. R., Lee, F. S., & Chao, M. V. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1405-10.2010 · Cited by 180
Self-citationBrain-derived neurotrophic factor and neuroplasticity in bipolar disorder
Kapczinski, F., Frey, B. N., Kauer-Sant’Anna, M., & Grassi-Oliveira, R. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.7.1101 · Cited by 181
The serotonin-BDNF duo: developmental implications for the vulnerability to psychopathology
Homberg, J. R., Molteni, R., Calabrese, F., & Riva, M. A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.012 · Cited by 177
Krishnan, V., Han, M.-H., Mazei-Robison, M., Iñiguez, S. D., Ables, J. L., Vialou, V., Berton, O., Ghose, S., Covington, H. E., Wiley, M. D., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.003 · Cited by 176
“Total BDNF levels in this fraction were estimated using a BDNF Emax ImmunoAssay kit (Promega, Madison, Wisconsin) with strict adherence to manufacturer protocols (15,29).”
MethodKemp, A. H., Gordon, E., Rush, A. J., & Williams, L. M. (2008) · CNS Spectrums · doi:10.1017/s1092852900017120 · Cited by 170
Convergent Mechanisms Underlying Rapid Antidepressant Action
Zanos, P., Thompson, S. M., Duman, R. S., Zarate, C. A., & Gould, T. D. (2018) · CNS Drugs · doi:10.1007/s40263-018-0492-x · Cited by 171
BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity
Bath, K. G., Jing, D. Q., Dincheva, I., Neeb, C. C., Pattwell, S. S., Chao, M. V., Lee, F. S., & Ninan, I. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.318 · Cited by 169
Self-citationMontag, C., Weber, B., Fliessbach, K., Elger, C., & Reuter, M. (2009) · Psychological Medicine · doi:10.1017/s0033291709005509 · Cited by 165
De Vincenti, A. P., Ríos, A. S., Paratcha, G., & Ledda, F. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00135 · Cited by 157
Selective early-acquired fear memories undergo temporary suppression during adolescence
Pattwell, S. S., Bath, K. G., Casey, B. J., Ninan, I., & Lee, F. S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012975108 · Cited by 161
Self-citationRemodeling of axo-spinous synapses in the pathophysiology and treatment of depression
Licznerski, P., & Duman, R. S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.057 · Cited by 157
Modeling psychiatric disorders for developing effective treatments
Kaiser, T., & Feng, G. (2015) · Nature Medicine · doi:10.1038/nm.3935 · Cited by 157
Pattwell, S. S., Bath, K. G., Perez-Castro, R., Lee, F. S., Chao, M. V., & Ninan, I. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5205-11.2012 · Cited by 156
Self-citationNeurotrophins, synaptic plasticity and dementia
Arancio, O., & Chao, M. V. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.03.013 · Cited by 156
Uysal, N., Kiray, M., Sisman, A., Camsari, U., Gencoglu, C., Baykara, B., Cetinkaya, C., & Aksu, I. (2015) · Biotechnic & Histochemistry · doi:10.3109/10520295.2014.946968 · Cited by 154
“It has been shown previously that BDNF-defi cient rats demonstrated aggressive behavior and intensifi ed anxietylike behavior (Chen et al. 2006).”
BackgroundNeurotrophins and Psychiatric Disorders
Castrén, E. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_17 · Cited by 150
GABAergic Control of Depression-Related Brain States
Luscher, B., & Fuchs, T. (2015) · Advances in Pharmacology · doi:10.1016/bs.apha.2014.11.003 · Cited by 149
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript resulted in increased anxiety- and depression-related behavior, increased vulnerability to stress and reduced responsiveness to the antidepressant fluoxetine (Z. Y. Chen et al., 2006; Yu et al., 2012).”
BackgroundAdvances in small molecules promoting neurotrophic function
PRICE, R., MILNE, S., SHARKEY, J., & MATSUOKA, N. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.005 · Cited by 148
BDNF signaling during the lifetime of dendritic spines
Zagrebelsky, M., Tacke, C., & Korte, M. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03226-5 · Cited by 147
BDNF control of adult SVZ neurogenesis
Bath, K. G., Akins, M. R., & Lee, F. S. (2012) · Developmental Psychobiology · doi:10.1002/dev.20546 · Cited by 146
Self-citationDeinhardt, K., & Chao, M. V. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_5 · Cited by 147
Harrisberger, F., Smieskova, R., Schmidt, A., Lenz, C., Walter, A., Wittfeld, K., Grabe, H. J., Lang, U. E., Fusar-Poli, P., & Borgwardt, S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.017 · Cited by 138
Carim-Todd, L., Bath, K. G., Fulgenzi, G., Yanpallewar, S., Jing, D., Barrick, C. A., Becker, J., Buckley, H., Dorsey, S. G., Lee, F. S., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5060-08.2009 · Cited by 138
Self-citationCdk5 Regulates Accurate Maturation of Newborn Granule Cells in the Adult Hippocampus
Jessberger, S., Aigner, S., Clemenson, G. D., Toni, N., Lie, D. C., Karalay, Ö., Overall, R., Kempermann, G., & Gage, F. H. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060272 · Cited by 134
Casey, B. J., Glatt, C. E., Tottenham, N., Soliman, F., Bath, K., Amso, D., Altemus, M., Pattwell, S., Jones, R., Levita, L., et al. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.081 · Cited by 129
Self-citationRedefining neuroendocrinology: Epigenetics of brain-body communication over the life course
McEwen, B. S. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.11.001 · Cited by 129
Self-citationWojnar, M., Brower, K. J., Strobbe, S., Ilgen, M., Matsumoto, H., Nowosad, I., Sliwerska, E., & Burmeister, M. (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00886.x · Cited by 125
Castrén, E., & Rantamäki, T. (2010) · CNS Drugs · doi:10.2165/11530010-000000000-00000 · Cited by 123
Morriss, J., Christakou, A., & van Reekum, C. M. (2015) · Biology of Mood & Anxiety Disorders · doi:10.1186/s13587-015-0019-8 · Cited by 106
Impact of Genetic Variant BDNF (Val66Met) on Brain Structure and Function
Chen, Z., Bath, K., McEwen, B., Hempstead, B., & Lee, F. (2008) · Novartis Foundation Symposia · doi:10.1002/9780470751251.ch14 · Cited by 119
Self-citationBDNF genotype moderates the relation between physical activity and depressive symptoms.
Mata, J., Thompson, R. J., & Gotlib, I. H. (2010) · Health Psychology · doi:10.1037/a0017261 · Cited by 119
Deyama, S., Bang, E., Kato, T., Li, X.-Y., & Duman, R. S. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.12.014 · Cited by 116
Mice with altered BDNF signaling as models for mood disorders and antidepressant effects
Lindholm, J. S. O., & Castrén, E. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00143 · Cited by 114
Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders
Galvez-Contreras, A. Y., Campos-Ordonez, T., Lopez-Virgen, V., Gomez-Plascencia, J., Ramos-Zuniga, R., & Gonzalez-Perez, O. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.08.004 · Cited by 112
Mechanisms of antidepressant resistance
El-Hage, W., Leman, S., Camus, V., & Belzung, C. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00146 · Cited by 111
Ghosal, S., Bang, E., Yue, W., Hare, B. D., Lepack, A. E., Girgenti, M. J., & Duman, R. S. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.017 · Cited by 111
Fuss, J., Ben Abdallah, N. M. B., Hensley, F. W., Weber, K.-J., Hellweg, R., & Gass, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012769 · Cited by 110
Brain-derived neurotrophic factor and schizophrenia
Di Carlo, P., Punzi, G., & Ursini, G. (2019) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000237 · Cited by 110
“, 2006), at the dendritic level, with a lowering of the complexity of the arborization (Chen et al., 2006).”
BackgroundInfluentialMueller, S. C., Aouidad, A., Gorodetsky, E., Goldman, D., Pine, D. S., & Ernst, M. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.11.016 · Cited by 103
Synaptic Mechanisms Regulating Mood State Transitions in Depression
Parekh, P. K., Johnson, S. B., & Liston, C. (2022) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-110920-040422 · Cited by 101
Deoxygedunin, a Natural Product with Potent Neurotrophic Activity in Mice
Jang, S.-W., Liu, X., Chan, C. B., France, S. A., Sayeed, I., Tang, W., Lin, X., Xiao, G., Andero, R., Chang, Q., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011528 · Cited by 101
Cazorla, M., Jouvenceau, A., Rose, C., Guilloux, J.-P., Pilon, C., Dranovsky, A., & Prémont, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009777 · Cited by 99
High abundance of BDNF within glutamatergic presynapses of cultured hippocampal neurons
Andreska, T., Aufmkolk, S., Sauer, M., & Blum, R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00107 · Cited by 100
Hajek, T., Kopecek, M., & Höschl, C. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.580005 · Cited by 99
Vigers, A. J., Amin, D. S., Talley-Farnham, T., Gorski, J. A., Xu, B., & Jones, K. R. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.031 · Cited by 95
Ota, K. T., & Duman, R. S. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.022 · Cited by 94
Cell biology of BDNF and its relevance to schizophrenia
Lu, B., & Martinowich, K. (2008) · Novartis Foundation Symposia · doi:10.1002/9780470751251.ch10 · Cited by 92
BDNF Release and Signaling Are Required for the Antidepressant Actions of GLYX-13
Kato, T., Fogaça, M. V., Deyama, S., Li, X.-Y., Fukumoto, K., & Duman, R. S. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.220 · Cited by 88
“We have reported that the antidepressant actions of ketamine are blocked in BDNF Met knock-in mice (18), a human polymorphism that blocks the processing and activity dependent release of mature BDNF (28).”
BackgroundMethodResultInfluentialSestrin modulator NV-5138 produces rapid antidepressant effects via direct mTORC1 activation
Kato, T., Pothula, S., Liu, R.-J., Duman, C. H., Terwilliger, R., Vlasuk, G. P., Saiah, E., Hahm, S., & Duman, R. S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126859 · Cited by 88
Subtle gene-environment interactions driving paranoia in daily life
Simons, C. J. P., Wichers, M., Derom, C., Thiery, E., Myin‐Germeys, I., Krabbendam, L., & Van Os, J. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00434.x · Cited by 82
Involvement of Brain-Derived Neurotrophic Factor in Late-Life Depression
Dwivedi, Y. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.10.026 · Cited by 86
BDNF Polymorphism and Differential rTMS Effects on Motor Recovery of Stroke Patients
Chang, W. H., Bang, O. Y., Shin, Y.-I., Lee, A., Pascual-Leone, A., & Kim, Y.-H. (2014) · Brain Stimulation · doi:10.1016/j.brs.2014.03.008 · Cited by 77
“Although an SNP in the BDNF gene does not affect the structure and function of the BDNF protein, it significantly impairs the intracellular trafficking and activity-dependent release of the protein [13,14].”
BackgroundLim, Y. Y., Hassenstab, J., Cruchaga, C., Goate, A., Fagan, A. M., Benzinger, T. L. S., Maruff, P., Snyder, P. J., Masters, C. L., Allegri, R., et al. (2016) · Brain · doi:10.1093/brain/aww200 · Cited by 76
Chen, L., Pan, H., Tuan, T. A., Teh, A. L., MacIsaac, J. L., Mah, S. M., McEwen, L. M., Li, Y., Chen, H., Broekman, B. F. P., et al. (2015) · Development and Psychopathology · doi:10.1017/s0954579414001357 · Cited by 75
“As noted above, transgenic BDNF Met/Met mice manifest increased anxious-like behaviors (Chen et al., 2006).”
BackgroundHippocampal network oscillations at the interplay between innate anxiety and learned fear
Çalışkan, G., & Stork, O. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5109-z · Cited by 72
Investigating the mechanism(s) underlying switching between states in bipolar disorder
Young, J. W., & Dulcis, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.019 · Cited by 68
“Given that this polymorphism has also been recreated in mice (Bath et al., 2012; Chen et al., 2006), testing the effects of pharmacological treatments or seasonal variation known to induce switching in any of these mouse lines on cross-species relevant behaviors could provide insight as to their…”
BackgroundSorLA Controls Neurotrophic Activity by Sorting of GDNF and Its Receptors GFRα1 and RET
Glerup, S., Lume, M., Olsen, D., Nyengaard, J. R., Vaegter, C. B., Gustafsen, C., Christensen, E. I., Kjolby, M., Hay-Schmidt, A., Bender, D., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2012.12.011 · Cited by 68
Pei, Y., Smith, A. K., Wang, Y., Pan, Y., Yang, J., Chen, Q., Pan, W., Bao, F., Zhao, L., Tie, C., et al. (2012) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32062 · Cited by 67
“Mice with the BDNF Met/Met genotype showed almost a 30% reduction in regulated release of BDNF [Chen et al., 2006].”
BackgroundAstrocytic BDNF signaling within the ventromedial hypothalamus regulates energy homeostasis
Ameroso, D., Meng, A., Chen, S., Felsted, J., Dulla, C. G., & Rios, M. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00566-0 · Cited by 67
Ignácio, Z. M., Réus, G. Z., Abelaira, H. M., & Quevedo, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.036 · Cited by 65
Woelfer, M., Li, M., Colic, L., Liebe, T., Di, X., Biswal, B., Murrough, J., Lessmann, V., Brigadski, T., & Walter, M. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2019.1679391 · Cited by 64
Wichers, M., Kenis, G., Jacobs, N., Myin-Germeys, I., Schruers, K., Mengelers, R., Delespaul, P., Derom, C., Vlietinck, R., & van Os, J. (2008) · Journal of Abnormal Psychology · doi:10.1037/a0012909 · Cited by 62
BDNF rs6265 methylation and genotype interact on risk for schizophrenia
Ursini, G., Cavalleri, T., Fazio, L., Angrisano, T., Iacovelli, L., Porcelli, A., Maddalena, G., Punzi, G., Mancini, M., Gelao, B., et al. (2016) · Epigenetics · doi:10.1080/15592294.2015.1117736 · Cited by 62
Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety
Molendijk, M. L., Bus, B. A. A., Spinhoven, P., Penninx, B. W. J. H., Prickaerts, J., Oude Voshaar, R. C., & Elzinga, B. M. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.587892 · Cited by 62
Metzger, M. W., Walser, S. M., Dedic, N., Aprile-Garcia, F., Jakubcakova, V., Adamczyk, M., Webb, K. J., Uhr, M., Refojo, D., Schmidt, M. V., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3487-16.2017 · Cited by 59
Diniz, C. R. A. F., Casarotto, P. C., Resstel, L., & Joca, S. R. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.04.001 · Cited by 58
McGuire, J. F., Lewin, A. B., & Storch, E. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.934677 · Cited by 57
Aldoghachi, A. F., Tor, Y. S., Redzun, S. Z., Lokman, K. A. B., Razaq, N. A. A., Shahbudin, A. F., Badamasi, I. M., Cheah, P.-S., Stanslas, J., Veerakumarasivam, A., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0211241 · Cited by 54
Murphy, G. M., Sarginson, J. E., Ryan, H. S., O’Hara, R., Schatzberg, A. F., & Lazzeroni, L. C. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328360b175 · Cited by 50
Anxiety in mice and men: a comparison
Hohoff, C. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0215-z · Cited by 50
“Such mouse strains represent promising models for humans, in whom—analogous to mice’ highanxiety-like traits—different anxious personalities and temperaments are defined ( Cattell 1950; Gray 1981 ;M cCrae and Costa 1990).”
Background(2019) · doi:10.1016/j.cmet.2018.12.018 · Cited by 49
Azadmarzabadi, E., Haghighatfard, A., & Mohammadi, A. (2018) · Psychogeriatrics · doi:10.1111/psyg.12312 · Cited by 46
Definition of a Bidirectional Activity-Dependent Pathway Involving BDNF and Narp
Mariga, A., Glaser, J., Mathias, L., Xu, D., Xiao, M., Worley, P., Ninan, I., & Chao, M. V. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.064 · Cited by 45
Sanchez, M. M., Das, D., Taylor, J. L., Noda, A., Yesavage, J. A., & Salehi, A. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.47 · Cited by 45
Jiang, C., Lin, W.-J., Labonté, B., Tamminga, C. A., Turecki, G., Nestler, E. J., Russo, S. J., & Salton, S. R. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0277-4 · Cited by 43
Association between the BDNF Val66Met Polymorphism and Chronicity of Depression
Lee, Y., Lim, S. W., Kim, S. Y., Chung, J. W., Kim, J., Myung, W., Song, J., Kim, S., Carroll, B. J., & Kim, D. K. (2013) · Psychiatry Investigation · doi:10.4306/pi.2013.10.1.56 · Cited by 41
Bortolozzi, A., Manashirov, S., Chen, A., & Artigas, F. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107873 · Cited by 37
Cazorla, M., Arrang, J., & Prémont, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01094.x · Cited by 35
Influence of BDNF genetic polymorphisms in the pathophysiology of aging-related diseases
Urbina-Varela, R., Soto-Espinoza, M. I., Vargas, R., Quiñones, L., & del Campo, A. (2020) · Aging and disease · doi:10.14336/ad.2020.0310 · Cited by 27
The relevance of BDNF for neuroprotection and neuroplasticity in multiple sclerosis
Maiworm, M. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1385042 · Cited by 27
Popova, D., Ágústsdóttir, A., Lindholm, J., Mazulis, U., Akamine, Y., Castrén, E., & Karpova, N. N. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.04.002 · Cited by 26
“Bdnf deficiency weakens hippocampal Bdnfinputs (Chen et al., 2006) and results in extinction impairment (Soliman et al.”
Boulle, F., Velthuis, H., Koedam, K., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., Gabriel, C., Mocaer, E., Franc, B., Rognan, D., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.003 · Cited by 24
Greenberg, G. D., van Westerhuyzen, J. A., Bales, K. L., & Trainor, B. C. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.063 · Cited by 24
Ren, L. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110910 · Cited by 23
Carlino, D., Francavilla, R., Baj, G., Kulak, K., d’Adamo, P., Ulivi, S., Cappellani, S., Gasparini, P., & Tongiorgi, E. (2015) · PeerJ · doi:10.7717/peerj.1252 · Cited by 23
Metadata
- Authors
- Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C.-J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., Hempstead, B. L., & Lee, F. S.
- Affiliations
- Shandong University (CN)
- Department of Psychiatry, Weill Medical College of Cornell University, New York, NY 10021, USA.
- Corresponding author
- Chen, Zhe-Yu
- Jing, Deqiang
- Bath, Kevin G.
- Lee, Francis S.
- ORCID
- Venue
- Science
- Published
- 2006-10-06
- Volume
- 314
- Issue
- 5796
- Pages
- 140-143
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC1880880
- OpenAlex
- W2050042714
- Cited by
- 1,340
- References
- 28
- Citations by year
- 2026: 21 · 2025: 40 · 2024: 40 · 2023: 56 · 2022: 53 · 2021: 64 · 2020: 85 · 2019: 64 · 2018: 68 · 2017: 69 · 2016: 76 · 2015: 104 · 2014: 83 · 2013: 83 · 2012: 92
- FWCI
- 22.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- IRIS eCampus Telematic University (Università degli Studi eCampus) (submittedVersion)
- Funders
- National Institute of Mental Health (K08MH068850, R25MH060478, MH-068850, MH060478)
- National Institute of Neurological Disorders and Stroke (NS30687, R01NS030687, NS052819, R01NS052819)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- brain-derived neurotrophic factor, BDNF Val66Met polymorphism, anxiety-like behavior, stress response, fluoxetine, depression, single nucleotide polymorphisms
- MeSH terms
- Alleles, Animals, Anxiety, Behavior, Animal, Conditioning, Psychological, Dendrites, Fear, Fluoxetine, Hippocampus, Memory, Mice, Inbred C57BL, Mice, Transgenic, Motor Activity, Neurons, Organ Size, Rats, Sprague-Dawley, Selective Serotonin Reuptake Inhibitors, Dentate Gyrus, Brain-Derived Neurotrophic Factor, Polymorphism, Single Nucleotide, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.